Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Florence Duffaud

Showing results (1-10 of 132) with videos related to

Pageof 14
Sort By:
Current Treatment Options in Oncology|July 1, 2020
Role of TKI for Metastatic Osteogenic SarcomaFlorence Duffaud
Targeted Oncology|April 4, 2009
Imatinib in the treatment of solid tumoursFlorence Duffaud, Axel Le Cesne
Oncology|December 6, 2003
Gastrointestinal stromal tumors: biology and treatmentFlorence Duffaud, Jean-Yves Blay
F1000Research|September 21, 2017
Recent advances in managing gastrointestinal stromal tumorFlorence Duffaud, Axel Le Cesne
F1000 Medicine Reports|October 16, 2010
Recent advances in the management of gastrointestinal stromal tumorsFlorence Duffaud, Sebastien Salas, Thanh Huynh
The New England Journal of Medicine|November 27, 2024
Doxorubicin-Trabectedin in Leiomyosarcoma. ReplyPatricia Pautier, Jean-Yves Blay, Florence Duffaud
Expert Review of Clinical Pharmacology|February 14, 2016
Treatment of advanced soft tissue sarcoma: efficacy and safety of trabectedin, a multitarget agent, and update on other systemic therapeutic optionsFlorence Duffaud, Robert G Maki, Robin L Jones
La Revue Du Praticien|December 5, 2018
Florence Duffaud, Marie Fichaux, Jean-Laurent Deville, et al.
F1000Prime Reports|June 23, 2015
Recent advances in understanding and managing leiomyosarcomasFlorence Duffaud, Isabelle Ray-Coquard, Sébastien Salas, et al.
European Journal of Cancer (Oxford, England : 1990)|September 12, 2021
Response to letter entitled: Re: Efficacy and safety of regorafenib in patients with metastatic or locally-advanced chondrosarcoma: Results of a non-comparative, randomised, double-blind, placebo controlled, multicentre phase II studyFlorence Duffaud, Camille Schiffler, Sylvie Chabaud, et al.
Pageof 14

Showing results (1-10 of 132) with videos related to

Sort By:
Pageof 14
Current Treatment Options in Oncology|July 1, 2020
Role of TKI for Metastatic Osteogenic SarcomaFlorence Duffaud
Targeted Oncology|April 4, 2009
Imatinib in the treatment of solid tumoursFlorence Duffaud, Axel Le Cesne
Oncology|December 6, 2003
Gastrointestinal stromal tumors: biology and treatmentFlorence Duffaud, Jean-Yves Blay
F1000Research|September 21, 2017
Recent advances in managing gastrointestinal stromal tumorFlorence Duffaud, Axel Le Cesne
F1000 Medicine Reports|October 16, 2010
Recent advances in the management of gastrointestinal stromal tumorsFlorence Duffaud, Sebastien Salas, Thanh Huynh
The New England Journal of Medicine|November 27, 2024
Doxorubicin-Trabectedin in Leiomyosarcoma. ReplyPatricia Pautier, Jean-Yves Blay, Florence Duffaud
Expert Review of Clinical Pharmacology|February 14, 2016
Treatment of advanced soft tissue sarcoma: efficacy and safety of trabectedin, a multitarget agent, and update on other systemic therapeutic optionsFlorence Duffaud, Robert G Maki, Robin L Jones
La Revue Du Praticien|December 5, 2018
Florence Duffaud, Marie Fichaux, Jean-Laurent Deville, et al.
F1000Prime Reports|June 23, 2015
Recent advances in understanding and managing leiomyosarcomasFlorence Duffaud, Isabelle Ray-Coquard, Sébastien Salas, et al.
European Journal of Cancer (Oxford, England : 1990)|September 12, 2021
Response to letter entitled: Re: Efficacy and safety of regorafenib in patients with metastatic or locally-advanced chondrosarcoma: Results of a non-comparative, randomised, double-blind, placebo controlled, multicentre phase II studyFlorence Duffaud, Camille Schiffler, Sylvie Chabaud, et al.
Pageof 14